Keyphrases
Gonadotropin-releasing Hormone
68%
Gonadotropins
45%
Ovarian Stimulation
44%
Ongoing Pregnancy Rate
35%
IVF Cycles
34%
In Vitro Fertilization
32%
Controlled Ovarian Stimulation
31%
Oocyte number
31%
IVF Outcome
29%
Poor Responders
28%
Retrospective Cohort Study
28%
Pregnancy Outcome
28%
Multifetal Pregnancy Reduction
28%
Mature Oocyte
25%
Pregnancy Rate
25%
Embryo Transfer
25%
Intracytoplasmic Sperm Injection
24%
High-quality Embryo
24%
Singleton
23%
Blastocyst
23%
Letrozole
23%
Final Follicular Maturation
23%
Perinatal Outcome
22%
Clinical Pregnancy Rate
22%
Human Chorionic Gonadotropin
21%
Twin Pregnancy
21%
Double Triggering
20%
Triplet
20%
Multiple Dose
19%
Preimplantation Genetic Diagnosis
18%
Final Oocyte Maturation
18%
Granulosa Cells
18%
Frozen Embryo Transfer
18%
Oocyte Yield
17%
Follicle
16%
Cycle Outcomes
16%
Embryo Quality
14%
Tertiary Care Hospital
14%
Cesarean Delivery
14%
Gene Expression
14%
IVF Treatment
13%
Vaginal Delivery
13%
Twin Gestation
13%
Week of Gestation
13%
Endometrial Thickness
13%
Singleton Pregnancy
13%
Ovarian Hyperstimulation Syndrome
12%
No Significant Difference
12%
Dual Trigger
12%
Spontaneous Ovarian Hyperstimulation Syndrome
12%
Medicine and Dentistry
Oocyte
100%
Pregnancy Rate
60%
Embryo Transfer
53%
Gonadotropin-Releasing Hormone
51%
Embryo Quality
39%
Pregnancy
36%
Cesarean Section
35%
In Vitro Fertilisation
34%
Gonadotropin
32%
Intracytoplasmic Sperm Injection
31%
Blastocyst
29%
Twin Pregnancy
27%
Retrospective Cohort Study
26%
Chorionic Gonadotropin
23%
Premature Labor
23%
Letrozole
23%
Maturation
22%
Follicle
20%
Obstetrics
19%
Oocyte Maturation
19%
Progesterone
18%
Vaginal Delivery
17%
Ovarian Hyperstimulation Syndrome
16%
Triplet Pregnancy
15%
Controlled Ovarian Hyperstimulation
15%
Childbirth
15%
Birth Rate
14%
Granulosa Cell
14%
Multiple Drug Dose
14%
Gene Expression
14%
Endometrium
13%
Fertilization
13%
Assisted Reproductive Technology
12%
Receptivity
12%
Genetic Screening
12%
Prospective Cohort Study
12%
Retrospective Study
12%
Gestational Age
11%
Oocyte Retrieval
11%
Odds Ratio
11%
Echography
11%
Gestational Diabetes
11%
Gonadorelin Agonist
10%
Malignant Neoplasm
10%
Prenatal Diagnosis
9%
Meta-Analysis
9%
Prostaglandin E2
9%
mRNA Vaccine
9%
COVID-19
9%
Randomized Controlled Trial
9%